undamentalytics Newsletter

Bausch & Lomb Corp key statistics and ratios

In fiscal 2025, Bausch & Lomb Corp had return on equity of -5.6%, an operating margin of 2.2%, debt equal to 79.2% of equity and a current ratio of 1.55. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bausch & Lomb Corp: financial ratios, annual
Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Operating margin7.6%8.7%5.5%3.1%3.4%2.2%7.1%
Net margin−0.5%4.8%0.2%−6.3%−6.6%−7.1%−2.0%
Free-cash-flow margin7.9%18.1%4.5%−4.8%−1.2%−1.3%4.7%
Return on equity−0.2%1.9%0.1%−3.7%−4.8%−5.6%−1.7%
Return on assets—1.7%0.1%−2.1%−2.4%−2.6%−0.8%
Asset turnover—0.350.340.340.360.370.39
Current ratio—1.491.651.741.601.551.56
Debt to equity0.0%0.0%35.4%67.7%74.8%79.2%78.7%
Interest cover (operating income ÷ interest)——1.4x0.5x0.4x0.3x1.0x
Effective tax rate—39.3%79.5%————
R&D as % of revenue7.4%7.2%8.1%7.8%7.2%7.3%7.4%
SG&A as % of revenue36.7%36.9%39.2%41.9%43.5%43.8%41.6%
Capital spending as % of revenue7.4%5.1%4.6%4.4%6.1%6.8%5.6%
Free cash flow ÷ net income—373.6%>999%————

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 7 checks passed · September 30, 2026
What it owns · $14.0bn
Short-term assets $3.1bnLonger-term assets $10.9bn
What it owes, and who funded it · $13.9bn
Short-term liabilities $2.0bnLonger-term liabilities $5.5bnShareholders' equity $6.4bn
  • Short-term assets cover short-term liabilities $3.1bn of assets due within a year against $2.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $3.1bn short-term assets against $5.5bn of longer-dated liabilities.
  • More cash than debt $513m of cash against $5.0bn of debt.
  • Debt below 40% of shareholders' equity Debt is 78% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 0% to 78% over five years.
  • A year's operating cash flow covers at least 20% of debt $554m of operating cash flow against $5.0bn of debt.
  • Operating profit covers interest at least five times over Operating income of $383m against $383m of interest.

From Bausch & Lomb Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

19 /100

Weak moat

How hard Bausch & Lomb's competitive advantage looks for rivals to wear away, judged from 5 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -1.6% of total assets over 5 years.

  • Durability 8 / 20

    Operating margin has been a median 3.3%; its worst year was 1.8%.

  • Cash conversion 4 / 20

    Free cash flow was positive in 2 of 5 years, at a median -0.5% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: BLCO vs RMDBLCO vs DXCMBLCO vs STEBLCO vs IDXX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bausch & Lomb Corp's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bausch & Lomb Corp.